These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1085 related articles for article (PubMed ID: 3260101)
1. Aminobisphosphonate inhibition of interleukin-1-induced bone resorption in mouse calvariae. Tan PL; Katz JM; Ames R; Caughey DE; Gray HD; Ibbertson HK; Watson JD Arthritis Rheum; 1988 Jun; 31(6):762-8. PubMed ID: 3260101 [TBL] [Abstract][Full Text] [Related]
2. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. Lerner UH J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770 [TBL] [Abstract][Full Text] [Related]
4. The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria. Reid IR; Katz JM; Ibbertson HK; Gray DH Calcif Tissue Int; 1986 Jan; 38(1):38-43. PubMed ID: 3079651 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism. Linkhart TA; MacCharles DC Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428 [TBL] [Abstract][Full Text] [Related]
6. Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha. Fried RM; Voelkel EF; Rice RH; Levine L; Gaffney EV; Tashjian AH Endocrinology; 1989 Aug; 125(2):742-51. PubMed ID: 2546747 [TBL] [Abstract][Full Text] [Related]
7. Role of IL-1 beta and prostaglandins in beta 2-microglobulin-induced bone mineral dissolution. Moe SM; Hack BK; Cummings SA; Sprague SM Kidney Int; 1995 Feb; 47(2):587-91. PubMed ID: 7723245 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibition of particulate-induced bone resorption. Horowitz SM; Algan SA; Purdon MA J Biomed Mater Res; 1996 May; 31(1):91-6. PubMed ID: 8731153 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. al-Humidan A; Ralston SH; Hughes DE; Chapman K; Aarden L; Russell RG; Gowen M J Bone Miner Res; 1991 Jan; 6(1):3-8. PubMed ID: 2048428 [TBL] [Abstract][Full Text] [Related]
10. Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures. Tarjan G; Stern PH J Bone Miner Res; 1995 Sep; 10(9):1321-6. PubMed ID: 7502703 [TBL] [Abstract][Full Text] [Related]
11. The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number. Piper K; Boyde A; Jones SJ Calcif Tissue Int; 1994 Jan; 54(1):56-61. PubMed ID: 8118755 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Hill PA; Docherty AJ; Bottomley KM; O'Connell JP; Morphy JR; Reynolds JJ; Meikle MC Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562 [TBL] [Abstract][Full Text] [Related]
13. Membrane IL-1 induces bone resorption in organ culture. Nishihara T; Ishihara Y; Noguchi T; Koga T J Immunol; 1989 Sep; 143(6):1881-6. PubMed ID: 2789251 [TBL] [Abstract][Full Text] [Related]
14. Effects of human 17 kDa interleukin 1, 25-31 kDa thymocyte stimulating activity and the 6-9 kDa interleukin 1 inhibitor on calcium release in the newborn murine calvarial assay. Watrous DA; Andrews BS; Levonian PJ; Friou GJ J Rheumatol; 1990 Sep; 17(9):1142-7. PubMed ID: 2290154 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 inhibits prostaglandin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures. Kawaguchi H; Nemoto K; Raisz LG; Harrison JR; Voznesensky OS; Alander CB; Pilbeam CC J Bone Miner Res; 1996 Mar; 11(3):358-66. PubMed ID: 8852946 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone. Conaway HH; Grigorie D; Lerner UH J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of bone resorption in cultures of mouse calvariae by apicularen A. Hong J; Sasaki H; Niikura K; Yanai M; Nakano Y; Yokomakura A; Ishihara K; Hirasawa N; Kang YS; Oh JS; Kwak JH; Zee O; Ohuchi K Planta Med; 2007 Feb; 73(2):173-5. PubMed ID: 17415879 [TBL] [Abstract][Full Text] [Related]
18. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors. Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859 [TBL] [Abstract][Full Text] [Related]
19. Bone resorbing activity released from zymosan-activated mouse peritoneal macrophages--the role of prostanoids and interleukin-1. Ohlin A; Sjögren U; Lerner UH Inflamm Res; 1999 Apr; 48(4):181-92. PubMed ID: 10344468 [TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha*. Nowak RA; Morrison NE; Goad DL; Gaffney EV; Tashjian AH Endocrinology; 1990 Dec; 127(6):3061-9. PubMed ID: 2174344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]